ClinicalTrials.govpublic full text
An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C
hepatitis, hepatitis c, cepeginterferon alfa, peginterferon, treatment, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906056
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.